BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

658 related articles for article (PubMed ID: 26703441)

  • 1. Soluble biglycan: a potential mediator of cartilage degradation in osteoarthritis.
    Barreto G; Soininen A; Ylinen P; Sandelin J; Konttinen YT; Nordström DC; Eklund KK
    Arthritis Res Ther; 2015 Dec; 17():379. PubMed ID: 26703441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synovial fluid levels of tumor necrosis factor alpha and oncostatin M correlate with levels of markers of the degradation of crosslinked collagen and cartilage aggrecan in rheumatoid arthritis but not in osteoarthritis.
    Manicourt DH; Poilvache P; Van Egeren A; Devogelaer JP; Lenz ME; Thonar EJ
    Arthritis Rheum; 2000 Feb; 43(2):281-8. PubMed ID: 10693867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of matrix metalloproteinases 2, 9, and 13 by activated protein C in human osteoarthritic cartilage chondrocytes.
    Jackson MT; Moradi B; Smith MM; Jackson CJ; Little CB
    Arthritis Rheumatol; 2014 Jun; 66(6):1525-36. PubMed ID: 24574263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Turnover of type II collagen and aggrecan in cartilage matrix at the onset of inflammatory arthritis in humans: relationship to mediators of systemic and local inflammation.
    Fraser A; Fearon U; Billinghurst RC; Ionescu M; Reece R; Barwick T; Emery P; Poole AR; Veale DJ
    Arthritis Rheum; 2003 Nov; 48(11):3085-95. PubMed ID: 14613270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The interaction of lubricin/proteoglycan 4 (PRG4) with toll-like receptors 2 and 4: an anti-inflammatory role of PRG4 in synovial fluid.
    Alquraini A; Garguilo S; D'Souza G; Zhang LX; Schmidt TA; Jay GD; Elsaid KA
    Arthritis Res Ther; 2015 Dec; 17():353. PubMed ID: 26643105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alarmins S100A8 and S100A9 elicit a catabolic effect in human osteoarthritic chondrocytes that is dependent on Toll-like receptor 4.
    Schelbergen RF; Blom AB; van den Bosch MH; Slöetjes A; Abdollahi-Roodsaz S; Schreurs BW; Mort JS; Vogl T; Roth J; van den Berg WB; van Lent PL
    Arthritis Rheum; 2012 May; 64(5):1477-87. PubMed ID: 22127564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High CCL18/PARC expression in articular cartilage and synovial tissue of patients with rheumatoid arthritis.
    Momohara S; Okamoto H; Iwamoto T; Mizumura T; Ikari K; Kawaguchi Y; Takeuchi M; Kamatani N; Tomatsu T
    J Rheumatol; 2007 Feb; 34(2):266-71. PubMed ID: 17304652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resistin as a factor in osteoarthritis: synovial fluid resistin concentrations correlate positively with interleukin 6 and matrix metalloproteinases MMP-1 and MMP-3.
    Koskinen A; Vuolteenaho K; Moilanen T; Moilanen E
    Scand J Rheumatol; 2014; 43(3):249-53. PubMed ID: 24780007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced suppressor of cytokine signaling 3 in arthritic cartilage dysregulates human chondrocyte function.
    van de Loo FA; Veenbergen S; van den Brand B; Bennink MB; Blaney-Davidson E; Arntz OJ; van Beuningen HM; van der Kraan PM; van den Berg WB
    Arthritis Rheum; 2012 Oct; 64(10):3313-23. PubMed ID: 22576756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased chondrocyte sclerostin may protect against cartilage degradation in osteoarthritis.
    Chan BY; Fuller ES; Russell AK; Smith SM; Smith MM; Jackson MT; Cake MA; Read RA; Bateman JF; Sambrook PN; Little CB
    Osteoarthritis Cartilage; 2011 Jul; 19(7):874-85. PubMed ID: 21619935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble receptors for tumor necrosis factor and interleukin-2 in serum and synovial fluid of patients with rheumatoid arthritis, reactive arthritis and osteoarthritis.
    Steiner G; Studnicka-Benke A; Witzmann G; Höfler E; Smolen J
    J Rheumatol; 1995 Mar; 22(3):406-12. PubMed ID: 7783054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Local cytokine profiles in knee osteoarthritis: elevated synovial fluid interleukin-15 differentiates early from end-stage disease.
    Scanzello CR; Umoh E; Pessler F; Diaz-Torne C; Miles T; Dicarlo E; Potter HG; Mandl L; Marx R; Rodeo S; Goldring SR; Crow MK
    Osteoarthritis Cartilage; 2009 Aug; 17(8):1040-8. PubMed ID: 19289234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Haem oxygenase-1 regulates catabolic and anabolic processes in osteoarthritic chondrocytes.
    Guillén M; Megías J; Gomar F; Alcaraz M
    J Pathol; 2008 Mar; 214(4):515-22. PubMed ID: 18200630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of hsa-miR-148a promotes cartilage production and inhibits cartilage degradation by osteoarthritic chondrocytes.
    Vonk LA; Kragten AH; Dhert WJ; Saris DB; Creemers LB
    Osteoarthritis Cartilage; 2014 Jan; 22(1):145-53. PubMed ID: 24269634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of collagen type II and proteoglycans in the synovial fluids of patients diagnosed with non-infectious knee joint synovitis indicates early damage to the articular cartilage matrix.
    Elsaid KA; Jay GD; Chichester CO
    Osteoarthritis Cartilage; 2003 Sep; 11(9):673-80. PubMed ID: 12954238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rheumatoid synovial fluid contains bioactive leukemia inhibitory factor with cartilage degrading activity--another target for chondroprotective intervention.
    Bell MC; Carroll GJ
    J Rheumatol; 2000 Feb; 27(2):332-8. PubMed ID: 10685793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated levels of synovial fluid antibodies reactive with the small proteoglycans biglycan and decorin in patients with rheumatoid arthritis or other joint diseases.
    Polgár A; Falus A; Koó E; Ujfalussy I; Seszták M; Szuts I; Konrád K; Hodinka L; Bene E; Mészáros G; Ortutay Z; Farkas E; Paksy A; Buzás EI
    Rheumatology (Oxford); 2003 Apr; 42(4):522-7. PubMed ID: 12649398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toll-like receptors and their soluble forms differ in the knee and thumb basal osteoarthritic joints.
    Barreto G; Sandelin J; Salem A; Nordström DC; Waris E
    Acta Orthop; 2017 Jun; 88(3):326-333. PubMed ID: 28093922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of synovial fluid markers of catabolism and anabolism in osteoarthritis, rheumatoid arthritis and asymptomatic organ donors.
    Kokebie R; Aggarwal R; Lidder S; Hakimiyan AA; Rueger DC; Block JA; Chubinskaya S
    Arthritis Res Ther; 2011 Mar; 13(2):R50. PubMed ID: 21435227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mast cell activation and its relation to proinflammatory cytokine production in the rheumatoid lesion.
    Woolley DE; Tetlow LC
    Arthritis Res; 2000; 2(1):65-74. PubMed ID: 11219391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.